Compliance Framework
Our sourcing standards for 503A compounding pharmacy compliance, cGMP manufacturing documentation, and state board requirements. Everything your pharmacy director needs to know about buying peptide API from us.
503A Sourcing Requirements for Peptide API
Section 503A of the Federal Food, Drug, and Cosmetic Act governs patient-specific compounding by licensed pharmacies. Under 503A, compounding pharmacies that use bulk drug substances — including peptide API — must source those substances from manufacturers that appear on the FDA's "Green List" (technically the List of Bulk Drug Substances That May Be Used By Outsourcing Facilities Under Section 503B) or have been approved through the 503A bulk drug substance evaluation pathway. Wholesale Peptide Distributors sources raw API exclusively from manufacturers with current FDA Drug Master Files (DMFs) and appropriate regulatory standing, and provides documentation to support pharmacy compliance programs.
What this means in practice: When your pharmacy purchases peptide API from Wholesale Peptide Distributors, you receive a supplier letter identifying the manufacturer, their DMF number (where applicable), and confirmation that raw material sourcing is consistent with 503A requirements. This documentation is designed to be submitted to your state board of pharmacy, accreditation body, or compliance auditor.
Our Documentation Package
Every wholesale order from Wholesale Peptide Distributors includes the following documentation package:
HPLC Chromatogram
Full chromatogram with integration report confirming purity ≥99% (peptides) or ≥98% (complex molecules). Lot-specific, not batch-average.
Mass Spectrometry Report
MS data confirming the molecular weight and sequence identity of each peptide lot. Prevents substitution and confirms structural integrity.
Endotoxin Test Result
LAL endotoxin testing per lot, target <1 EU/mg. Results reported with the specific lot number and testing date.
Residual Solvent Analysis
Residual solvent profile per ICH Q3C guidelines. Results confirm compliance with Class 2 and Class 3 solvent limits.
Supplier Letter
Letter on company letterhead identifying manufacturer, facility location, and regulatory standing. Can be provided to state boards and accreditors.
SDS (Safety Data Sheet)
Safety data sheet per OSHA Hazard Communication Standard (29 CFR 1910.1200) for all substances. Required for USP <797> SOP compliance.
Manufacturing Standards
All Wholesale Peptide Distributors peptide API is synthesized in the United States in facilities that operate under the following standards:
- ISO 5 (Class 100) Cleanroom Environment — Particulate control at the cleanest classification required for injectable product manufacturing. Air particle counts monitored and recorded.
- cGMP-Aligned Processes — Manufacturing procedures aligned with current Good Manufacturing Practice guidelines, including batch records, in-process controls, and finished product release testing.
- Solid-Phase Peptide Synthesis (SPPS) — Fmoc SPPS methodology with HPLC purification at multiple stages. Synthesis equipment is dedicated and cleaned between campaigns.
- Cold Chain Storage — Finished peptide API stored at −20°C with continuous temperature monitoring until shipment. Stability data available for key products.
- Full Lot Traceability — Every lot has a unique identifier traceable from raw material receipt through synthesis, testing, and shipment. Traceability records retained for 7 years minimum.
Eligibility Requirements
Wholesale Peptide Distributors sells exclusively to the following licensed entities:
- 503A compounding pharmacies licensed by their state board of pharmacy
- 503B outsourcing facilities registered with the FDA
- Licensed physicians, nurse practitioners, and other prescribers operating in-office dispensing programs
- Licensed medical clinics operating within the scope of applicable state law
- Medspa chains operating under physician supervision with appropriate DEA/state licensure
- Commercial distributors and sub-distributors with appropriate licensure
All wholesale accounts are required to submit a copy of their state pharmacy license or medical license, a signed Wholesale Account Agreement, and confirm their intended use at the time of application. We reserve the right to verify licensure before fulfilling any order and to terminate accounts found to be in violation of our use policies.
Questions About Our Compliance Documentation?
Our compliance team is available to answer questions about our documentation package, sourcing standards, and how our CoA materials can support your state board or accreditation requirements.